Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 5
1982 6
1983 8
1984 47
1985 52
1986 71
1987 76
1988 89
1989 68
1990 68
1991 115
1992 70
1993 64
1994 102
1995 141
1996 114
1997 113
1998 94
1999 95
2000 89
2001 126
2002 107
2003 90
2004 90
2005 92
2006 102
2007 94
2008 126
2009 103
2010 131
2011 139
2012 114
2013 146
2014 107
2015 140
2016 129
2017 141
2018 111
2019 102
2020 100
2021 108
2022 96
2023 59
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

3,695 results

Results by year

Filters applied: . Clear all
Page 1
Phase-1 clinical trial results of high-specific-activity carrier-free 123I-iobenguane.
Chin BB, Kronauge JF, Femia FJ, Chen J, Maresca KP, Hillier S, Petry NA, James OG, Oldan JD, Armor T, Stubbs JB, Stabin MG, Babich JW. Chin BB, et al. J Nucl Med. 2014 May;55(5):765-71. doi: 10.2967/jnumed.113.124057. Epub 2014 Mar 13. J Nucl Med. 2014. PMID: 24627436 Free article. Clinical Trial.
RESULTS: A reference clinical imaging database acquired over time for healthy men and women injected with high-specific-activity (123)I-iobenguane showed organ distribution and whole-body retention similar to those of conventional (123)I-iobenguane. ...CONCLUSION: H …
RESULTS: A reference clinical imaging database acquired over time for healthy men and women injected with high-specific-activity (123)I-i
123I-mIBG and the phantom tollbooth.
Flotats A, Carrió I. Flotats A, et al. J Nucl Cardiol. 2018 Aug;25(4):1198-1200. doi: 10.1007/s12350-017-0843-x. Epub 2017 Mar 13. J Nucl Cardiol. 2018. PMID: 28290101 No abstract available.
Extended stability of iobenguane under simulated clinical conditions.
Hinkle GH, Dura JV, Morosco RS, Nahata MC. Hinkle GH, et al. Am J Health Syst Pharm. 2008 Jan 15;65(2):142-4. doi: 10.2146/ajhp070247. Am J Health Syst Pharm. 2008. PMID: 18192259
PURPOSE: The stability of iobenguane sulfate stored at 4-7 degrees C over 91 days was studied. METHODS: An iobenguane sulfate solution at a concentration of 2.2 mg/mL was prepared in a top-fill i.v. bag using 143 mg of iobenguane sulfate and 65 mL of Sterile …
PURPOSE: The stability of iobenguane sulfate stored at 4-7 degrees C over 91 days was studied. METHODS: An iobenguane sulfate …
123I-mIBG: Simplicity and reproducibility.
Curl K, Hansen CL. Curl K, et al. J Nucl Cardiol. 2019 Oct;26(5):1566-1568. doi: 10.1007/s12350-018-1196-9. Epub 2018 Jan 29. J Nucl Cardiol. 2019. PMID: 29380284 No abstract available.
Role of I-123 MIBG in sepsis-induced cardiomyopathy.
Waqar F, Jamali HK, Gerson MC. Waqar F, et al. J Nucl Cardiol. 2018 Apr;25(2):492-495. doi: 10.1007/s12350-016-0659-0. Epub 2016 Sep 8. J Nucl Cardiol. 2018. PMID: 27638742 No abstract available.
MIBG in neuroblastoma diagnosis and treatment.
Olecki E, Grant CN. Olecki E, et al. Semin Pediatr Surg. 2019 Dec;28(6):150859. doi: 10.1016/j.sempedsurg.2019.150859. Epub 2019 Nov 20. Semin Pediatr Surg. 2019. PMID: 31931960 Review.
3,695 results